EUVIMEDEUVIMED entdecken
Crossref

Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder

Marion Wobser iD, Silke Appenzeller, Sabine Roth, Claudia Siedel, Matthias Goebeler, Eva Geissinger, Andreas Rosenwald, Katja Maurus

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Marion Wobser und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology and Skin Cancer Center, University Hospital Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Skin Neoplasms, CD8-Positive T-Lymphocytes, Receptors, KIR3DL1, Lymphoma, T-Cell, Cutaneous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary cutaneous acral CD8+ T-cell lymphoproliferative disorder (TLPD) is a rare and indolent lymphoma entity. Although TLPD was first identified many years ago, the molecular pathogenesis is still not fully understood.

Objectives

In order to better understand the molecular pathogenesis of cutaneous acral CD8+ TLPD and to identify further discriminatory markers to differentiate this lymphoma subtype from other CD8+ cutaneous lymphomas, we analysed five cases of cutaneous acral CD8+ TLPD for putative molecular alterations.

Methods

Somatic alterations were assessed using whole-exome and targeted sequencing of paraffin-embedded tissue. Results were evaluated using immunohistochemical staining of respective relevant proteins. CD8+ cutaneous T-cell lymphomas (n = 12) served as control for KIR3DL1 staining.

Results

Copy number variation analysis revealed a homozygous deletion of the KIR3DL1 gene in two of the analysed cases. This resulted in loss of KIR3DL1 protein expression, which was observed in all cases of cutaneous acral CD8+ TLPD. In contrast, KIR3DL1 expression was more variable in other CD8+ cutaneous T-cell lymphomas with 50% of analysed cases (n = 12) found to be positive. In addition, one further case of acral CD8+ TLPD harboured a loss-of-function mutation in the PIK3R1 gene, presumably activating the phosphoinositide 3-kinase-AKT pathway.

Conclusions

Alterations of the KIR3DL1 gene may be of pathogenetic relevance for acral CD8+ TLPD. Loss of KIR3DL1 protein expression may support the diagnosis of this indolent lymphoma entity; however, this is not a subtype-specific discriminative feature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCD8-Positive T-LymphocytesReceptors, KIR3DL1Lymphoma, T-Cell, CutaneousHumansMaleFemaleMiddle AgedDNA Copy Number VariationsAgedExome SequencingMutationAdult

Substanzen

Receptors, KIR3DL1KIR3DL1 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology and Skin Cancer Center, University Hospital Würzburg, Würzburg, Germany.
  • Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.
  • Institute of Pathology, University of Würzburg, Würzburg, Germany.
  • Pathology Practice, Ingolstadt, Germany.

ORCID-Profile: Marion Wobser

Zitieren

APA

Wobser, M., Appenzeller, S., Roth, S., Siedel, C., Goebeler, M., Geissinger, E., Rosenwald, A., & Maurus, K. (2024). Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae256

Vancouver

Wobser M, Appenzeller S, Roth S, Siedel C, Goebeler M, Geissinger E, et al. Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae256

BibTeX
@article{Wobser2024,
  author = {Wobser, Marion and Appenzeller, Silke and Roth, Sabine and Siedel, Claudia and Goebeler, Matthias and Geissinger, Eva and Rosenwald, Andreas and Maurus, Katja},
  title = {Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae256}
}
Kostenlos starten →